頁面路徑選單
Radiation Dose Management Market by Product (Dose Tracking, Monitoring, and Analytics Software, Consulting Services), by Application (Computed Tomography, Angiography, Fluoroscopy), by End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2020
出 版 商：MarketsandMarkets
出版日期：2015/03/18
頁 數：179頁
文件格式：PDF
價 格：
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
Presently, radiation dose management is a rising concern in the healthcare industry. The radiation dose management market is experiencing tremendous growth owing to the increasing demand for patient safety and adherence to stringent regulations regarding patient dose exposure. The advent of radiation dose management solutions has modernized the management of radiation dose in radiology departments while improving the patient safety in a drastic manner. These solutions are also supporting the meaningful use of EHRs and EMRs by helping in the maintenance of complete patient medical records in those systems. Growth in this market is primarily attributed to the need to maintain accurate radiation dose information of each patient to increase patient safety and improve healthcare services, manage and optimize patient radiation dose in healthcare systems with greater efficiency, and reduce compliance risks.
In this report, the radiation dose management market is segmented by products, applications, and end users. By products, the market is segmented into software and services. The software market is further subdivided into dose tracking, monitoring, and analytics software and post-image processing software. The services market is subdivided into implementation and integration services, support and maintenance services, consulting services, and education and training services. By application, the market is divided into computed tomography, fluoroscopy and interventional imaging, mammography, radiography, and others. The market is further segmented by end users into hospitals and clinics, diagnostic centers, and research and academic medical centers.
The global radiation dose management market is expected to grow at a CAGR of around 50% during the forecast period of 2015 to 2020. The market is mainly driven by the rising diagnostic imaging procedures performed across the globe, increasing risks of life-threatening diseases owing to the biological effects of radiation, stringent accreditation and regulatory requirements regarding radiation safety, and need to increase clinical efficiency and to improve quality of healthcare services.
Moreover, increasing awareness for radiation safety among patients, physicians, and technicians; and various dose management campaigns for increasing patient safety across the globe are further propelling the growth of this market. Various factors such as increased use of interventional imaging and nuclear medicine in medical imaging, and technology advancements for radiation dose management systems are providing significant growth opportunities for the market. However, factors such as lack of funding, lack of standardized protocols, and ignorance of technicians and physicians in healthcare organizations towards risks associated with radiation exposure are restraining the growth of this market up to a certain extent.
Presently, the dose tracking, monitoring, and analytics software segment forms a major portion of the radiation dose management software market. This is attributed to the compliance achieved by integrating radiation dose tracking, monitoring, and analytics software with other systems such as EHR, PACS, and RIS to monitor, track, and archive the patient dose information and to improve patient safety.
By 2020, North America contributed the largest share to the global radiation dose management market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at higher CAGRs. However, the Asia-Pacific market is also showing a healthy CAGR during the forecast period, largely driven by the rising number of multispecialty hospitals, increased awareness among patients, increased healthcare spending, government initiatives for e-Health, and rising medical tourism in the region.
Prominent players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.K.), PACSHealth LLC (U.S.), Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.) Siemens Healthcare (Germany), AGFA Healthcare (Belgium), Sectra Medical Systems (Sweden), Toshiba Medical Systems Corporation (Japan), and McKesson Corporation (U.S.).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping greater market shares.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolios offered by the top players in the radiation dose management market. The report analyzes the radiation dose management systems market by product, application, and end user across all regions
‧ Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the radiation dose management market
‧ Market Development: Comprehensive information on lucrative emerging markets by product, application, end user, and geography
‧ Market Diversification: Exhaustive information on new products, growing regions, recent developments, and investments in the radiation dose management market
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and analysis of the leading players in the radiation dose management market
In this report, the radiation dose management market is segmented by products, applications, and end users. By products, the market is segmented into software and services. The software market is further subdivided into dose tracking, monitoring, and analytics software and post-image processing software. The services market is subdivided into implementation and integration services, support and maintenance services, consulting services, and education and training services. By application, the market is divided into computed tomography, fluoroscopy and interventional imaging, mammography, radiography, and others. The market is further segmented by end users into hospitals and clinics, diagnostic centers, and research and academic medical centers.
The global radiation dose management market is expected to grow at a CAGR of around 50% during the forecast period of 2015 to 2020. The market is mainly driven by the rising diagnostic imaging procedures performed across the globe, increasing risks of life-threatening diseases owing to the biological effects of radiation, stringent accreditation and regulatory requirements regarding radiation safety, and need to increase clinical efficiency and to improve quality of healthcare services.
Moreover, increasing awareness for radiation safety among patients, physicians, and technicians; and various dose management campaigns for increasing patient safety across the globe are further propelling the growth of this market. Various factors such as increased use of interventional imaging and nuclear medicine in medical imaging, and technology advancements for radiation dose management systems are providing significant growth opportunities for the market. However, factors such as lack of funding, lack of standardized protocols, and ignorance of technicians and physicians in healthcare organizations towards risks associated with radiation exposure are restraining the growth of this market up to a certain extent.
Presently, the dose tracking, monitoring, and analytics software segment forms a major portion of the radiation dose management software market. This is attributed to the compliance achieved by integrating radiation dose tracking, monitoring, and analytics software with other systems such as EHR, PACS, and RIS to monitor, track, and archive the patient dose information and to improve patient safety.
By 2020, North America contributed the largest share to the global radiation dose management market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at higher CAGRs. However, the Asia-Pacific market is also showing a healthy CAGR during the forecast period, largely driven by the rising number of multispecialty hospitals, increased awareness among patients, increased healthcare spending, government initiatives for e-Health, and rising medical tourism in the region.
Prominent players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.K.), PACSHealth LLC (U.S.), Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.) Siemens Healthcare (Germany), AGFA Healthcare (Belgium), Sectra Medical Systems (Sweden), Toshiba Medical Systems Corporation (Japan), and McKesson Corporation (U.S.).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping greater market shares.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolios offered by the top players in the radiation dose management market. The report analyzes the radiation dose management systems market by product, application, and end user across all regions
‧ Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the radiation dose management market
‧ Market Development: Comprehensive information on lucrative emerging markets by product, application, end user, and geography
‧ Market Diversification: Exhaustive information on new products, growing regions, recent developments, and investments in the radiation dose management market
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and analysis of the leading players in the radiation dose management market
TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
4.1 GROWTH POTENTIAL OF THE RADIATION DOSE MANAGEMENT SYSTEMS MARKET 33
4.2 NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT 34
4.3 RADIATION DOSE MANAGEMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 35
4.4 RADIATION DOSE MANAGEMENT MARKET: REGIONAL MIX 36
4.5 RADIATION DOSE MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.3 MARKET DYNAMICS 40
5.4 MARKET DRIVERS 40
5.4.1 GROWING REGULATORY, LEGISLATORY, AND ACCREDITATION REQUIREMENTS FOR RADIATION DOSE MANAGEMENT 40
5.4.2 INCREASING CONCERNS OVER RADIATION OVEREXPOSURE 41
5.4.3 GROWING AWARENESS AMONG STAKEHOLDERS AND INDUSTRY INITIATIVES FOR RADIATION DOSE MANAGEMENT 42
5.5 MARKET RESTRAINTS 43
5.5.1 LACK OF AWARENESS AMONG MEDICAL PROFESSIONALS AND LACK OF SKILLED OPERATORS 43
5.5.2 LOWER ADOPTION OF RADIATION DOSE MANAGEMENT SOFTWARE IN EMERGING MARKETS 43
5.6 MARKET OPPORTUNITIES 44
5.6.1 TECHNOLOGICAL ADVANCEMENTS 44
5.6.2 INTERVENTIONAL RADIOLOGY AND NUCLEAR MEDICINE 45
5.7 CHALLENGES 45
5.7.1 LACK OF BENCHMARKING FOR DOSE OPTIMIZATION ACROSS THE GLOBE 45
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 INDUSTRY TRENDS 47
6.3 PORTER’S FIVE FORCES ANALYSIS 48
6.3.1 THREAT OF NEW ENTRANTS 48
6.3.2 THREAT OF SUBSTITUTES 49
6.3.3 BARGAINING POWER OF SUPPLIERS 49
6.3.4 BARGAINING POWER OF BUYERS 49
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.4 STRATEGIC BENCHMARKING 50
6.4.1 PARTNERSHIPS, COLLABORATIONS, AND ACQUISITIONS: THE MOST WIDELY ADOPTED STRATEGY 50
7 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT TYPE 52
7.1 INTRODUCTION 53
7.2 RADIATION DOSE MANAGEMENT SOFTWARE MARKET 54
7.2.1 RADIATION DOSE TRACKING, MONITORING, AND ANALYTICS SOFTWARE 56
7.2.2 POST-IMAGE PROCESSING SOFTWARE 58
7.3 RADIATION DOSE MANAGEMENT SERVICES MARKET 59
7.3.1 IMPLEMENTATION AND INTEGRATION SERVICES 61
7.3.2 SUPPORT AND MAINTENANCE SERVICES 62
7.3.3 EDUCATION & TRAINING SERVICES 63
7.3.4 CONSULTING SERVICES 64
8 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION 66
8.1 INTRODUCTION 67
8.2 COMPUTED TOMOGRAPHY 69
8.3 FLUOROSCOPY AND INTERVENTIONAL IMAGING 70
8.4 NUCLEAR MEDICINE 72
8.5 RADIOGRAPHY AND MAMMOGRAPHY 73
9 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY END USER 75
9.1 INTRODUCTION 76
9.2 HOSPITALS 78
9.3 DIAGNOSTIC CENTERS 80
9.4 RESEARCH INSTITUTES AND ACADEMIC MEDICAL CENTERS 81
10 RADIATION DOSE MANAGEMENT MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 U.S. 89
10.2.2 CANADA 92
10.3 EUROPE 95
10.3.1 FRANCE 99
10.3.2 U.K. 102
10.3.3 ITALY 105
10.3.4 GERMANY 108
10.3.5 SPAIN 111
10.3.6 ROE 114
10.4 ASIA-PACIFIC 117
10.4.1 JAPAN 121
10.4.2 REST OF ASIA-PACIFIC 124
10.5 REST OF THE WORLD (ROW) 128
10.5.1 LATIN AMERICA 130
10.5.1 MIDDLE EAST AND AFRICA 133
11 COMPETITIVE LANDSCAPE 136
11.1 OVERVIEW 136
11.2 MARKET SHARE ANALYSIS 137
11.3 COMPETITIVE SITUATION AND TRENDS 139
11.3.1 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES 140
11.3.2 NEW PRODUCT LAUNCHES 141
11.3.3 MERGERS AND ACQUISITIONS 142
11.3.4 OTHER DEVELOPMENTS 143
12 COMPANY PROFILES 144
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 BAYER AG 145
12.2 GE HEALTHCARE 148
12.3 SECTRA AB 151
12.4 PACSHEALTH LLC 153
12.5 PHILIPS HEALTHCARE (PHILIPS) 155
12.6 AGFA HEALTHCARE 157
12.7 FUJIFILM HOLDINGS CORPORATION 159
12.8 MCKESSON CORPORATION 161
12.9 NOVARAD CORPORATION 163
12.10 TOSHIBA MEDICAL SYSTEMS CORPORATION 164
12.11 SIEMENS HEALTHCARE (SIEMENS AG) 167
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
13 APPENDIX 169
13.1 INSIGHTS OF INDUSTRY EXPERTS 169
13.2 DISCUSSION GUIDE 170
13.3 RECENT DEVELOPMENTS, BY MARKET PLAYER, 2012–2015 174
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 176
13.5 AVAILABLE CUSTOMIZATIONS 177
13.6 RELATED REPORTS 178
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
4.1 GROWTH POTENTIAL OF THE RADIATION DOSE MANAGEMENT SYSTEMS MARKET 33
4.2 NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT 34
4.3 RADIATION DOSE MANAGEMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 35
4.4 RADIATION DOSE MANAGEMENT MARKET: REGIONAL MIX 36
4.5 RADIATION DOSE MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.3 MARKET DYNAMICS 40
5.4 MARKET DRIVERS 40
5.4.1 GROWING REGULATORY, LEGISLATORY, AND ACCREDITATION REQUIREMENTS FOR RADIATION DOSE MANAGEMENT 40
5.4.2 INCREASING CONCERNS OVER RADIATION OVEREXPOSURE 41
5.4.3 GROWING AWARENESS AMONG STAKEHOLDERS AND INDUSTRY INITIATIVES FOR RADIATION DOSE MANAGEMENT 42
5.5 MARKET RESTRAINTS 43
5.5.1 LACK OF AWARENESS AMONG MEDICAL PROFESSIONALS AND LACK OF SKILLED OPERATORS 43
5.5.2 LOWER ADOPTION OF RADIATION DOSE MANAGEMENT SOFTWARE IN EMERGING MARKETS 43
5.6 MARKET OPPORTUNITIES 44
5.6.1 TECHNOLOGICAL ADVANCEMENTS 44
5.6.2 INTERVENTIONAL RADIOLOGY AND NUCLEAR MEDICINE 45
5.7 CHALLENGES 45
5.7.1 LACK OF BENCHMARKING FOR DOSE OPTIMIZATION ACROSS THE GLOBE 45
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 INDUSTRY TRENDS 47
6.3 PORTER’S FIVE FORCES ANALYSIS 48
6.3.1 THREAT OF NEW ENTRANTS 48
6.3.2 THREAT OF SUBSTITUTES 49
6.3.3 BARGAINING POWER OF SUPPLIERS 49
6.3.4 BARGAINING POWER OF BUYERS 49
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.4 STRATEGIC BENCHMARKING 50
6.4.1 PARTNERSHIPS, COLLABORATIONS, AND ACQUISITIONS: THE MOST WIDELY ADOPTED STRATEGY 50
7 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT TYPE 52
7.1 INTRODUCTION 53
7.2 RADIATION DOSE MANAGEMENT SOFTWARE MARKET 54
7.2.1 RADIATION DOSE TRACKING, MONITORING, AND ANALYTICS SOFTWARE 56
7.2.2 POST-IMAGE PROCESSING SOFTWARE 58
7.3 RADIATION DOSE MANAGEMENT SERVICES MARKET 59
7.3.1 IMPLEMENTATION AND INTEGRATION SERVICES 61
7.3.2 SUPPORT AND MAINTENANCE SERVICES 62
7.3.3 EDUCATION & TRAINING SERVICES 63
7.3.4 CONSULTING SERVICES 64
8 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION 66
8.1 INTRODUCTION 67
8.2 COMPUTED TOMOGRAPHY 69
8.3 FLUOROSCOPY AND INTERVENTIONAL IMAGING 70
8.4 NUCLEAR MEDICINE 72
8.5 RADIOGRAPHY AND MAMMOGRAPHY 73
9 GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY END USER 75
9.1 INTRODUCTION 76
9.2 HOSPITALS 78
9.3 DIAGNOSTIC CENTERS 80
9.4 RESEARCH INSTITUTES AND ACADEMIC MEDICAL CENTERS 81
10 RADIATION DOSE MANAGEMENT MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 U.S. 89
10.2.2 CANADA 92
10.3 EUROPE 95
10.3.1 FRANCE 99
10.3.2 U.K. 102
10.3.3 ITALY 105
10.3.4 GERMANY 108
10.3.5 SPAIN 111
10.3.6 ROE 114
10.4 ASIA-PACIFIC 117
10.4.1 JAPAN 121
10.4.2 REST OF ASIA-PACIFIC 124
10.5 REST OF THE WORLD (ROW) 128
10.5.1 LATIN AMERICA 130
10.5.1 MIDDLE EAST AND AFRICA 133
11 COMPETITIVE LANDSCAPE 136
11.1 OVERVIEW 136
11.2 MARKET SHARE ANALYSIS 137
11.3 COMPETITIVE SITUATION AND TRENDS 139
11.3.1 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES 140
11.3.2 NEW PRODUCT LAUNCHES 141
11.3.3 MERGERS AND ACQUISITIONS 142
11.3.4 OTHER DEVELOPMENTS 143
12 COMPANY PROFILES 144
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 BAYER AG 145
12.2 GE HEALTHCARE 148
12.3 SECTRA AB 151
12.4 PACSHEALTH LLC 153
12.5 PHILIPS HEALTHCARE (PHILIPS) 155
12.6 AGFA HEALTHCARE 157
12.7 FUJIFILM HOLDINGS CORPORATION 159
12.8 MCKESSON CORPORATION 161
12.9 NOVARAD CORPORATION 163
12.10 TOSHIBA MEDICAL SYSTEMS CORPORATION 164
12.11 SIEMENS HEALTHCARE (SIEMENS AG) 167
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
13 APPENDIX 169
13.1 INSIGHTS OF INDUSTRY EXPERTS 169
13.2 DISCUSSION GUIDE 170
13.3 RECENT DEVELOPMENTS, BY MARKET PLAYER, 2012–2015 174
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 176
13.5 AVAILABLE CUSTOMIZATIONS 177
13.6 RELATED REPORTS 178
